Table I.
Clinicopathological characteristics of patient samples and expression of SPOPL in medulloblastoma.
| Clinicopathological characteristic | No. of cases (%) |
|---|---|
| Age, years | |
| ≤3 | 5 (8.6) |
| >3 | 53 (91.4) |
| Sex | |
| Male | 46 (79.3) |
| Female | 12 (20.7) |
| WHO histological subtype | |
| Classic | 44 (75.9) |
| Desmoplastic | 14 (24.1) |
| Residual tumor size, cm2 | |
| <1.5 | 44 (75.9) |
| ≥1.5 | 14 (24.1) |
| Metastatic status | |
| M0 | 25 (43.1) |
| M1 | 33 (56.9) |
| Tumor risk | |
| Standard | 17 (29.3) |
| High | 41 (70.7) |
| Differentiation level | |
| Undifferentiated | 19 (32.8) |
| Differentiated | 39 (67.2) |
| Expression of SPOPL | |
| Negative | 2 (3.4) |
| Positive | 56 (96.6) |
| Low | 42 (75) |
| High | 14 (25) |
WHO, World Health Organization; SPOPL, Speckle-type POZ protein-like.